Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04417465
Title First In Human Study With ABBV-CLS-579 When Given Alone Or In Combination With Programmed Cell Death-1 Inhibitor In Participants With Locally Advanced Or Metastatic Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Calico Life Sciences LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.